Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/07/2002 | US20020165164 New effectors of dipeptidyl peptidase IV for topical use |
11/07/2002 | US20020165163 Inhibits the binding of tumor necrosis factor(TNF) to its receptors, and the cytotoxic effect of TNF; non-proteolytic protein isolated from human urine, of given amino acid sequence |
11/07/2002 | US20020165162 Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
11/07/2002 | US20020165161 Chemokine-binding proteins for treating congestive heart failure |
11/07/2002 | US20020165160 Fibroblast growth factor (FGF) mutein; treating coronary artery disease (atherosclerosis) |
11/07/2002 | US20020165159 Administering a luteinizing hormone releasing hormone antagonist or agonist peptide to selectively change the amount of follicle- stimulating hormone (FSH) in blood to control fertility |
11/07/2002 | US20020165158 Administering protein kinase C inhibitors |
11/07/2002 | US20020165156 Tumor necrosis factor family and its blocking agent |
11/07/2002 | US20020165155 Crystallization of IGF-1 |
11/07/2002 | US20020165154 Lipoprotein-regulating medicaments |
11/07/2002 | US20020165153 DNA binding domain of a basic domain and an adjacent leucine zipper domain |
11/07/2002 | US20020165152 14089, a novel human trypsin serine protease and uses thereof |
11/07/2002 | US20020165151 Promoting smooth muscle cell growth or vasculogenesis with an antibody that reacts with the protein |
11/07/2002 | US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
11/07/2002 | US20020165148 Analogues and derivatives of gastrin releasing peptide (GRP) |
11/07/2002 | US20020165147 Treating seizures or epilepsy |
11/07/2002 | US20020165146 Follicle stimulating hormone (FSH) products used in the treatment of infertility |
11/07/2002 | US20020165145 Encode Rho GEF protein members |
11/07/2002 | US20020165144 Neuregulin 1 gene (NRG1) and polypeptides |
11/07/2002 | US20020165143 Identification and isolation of novel DNA |
11/07/2002 | US20020165141 Methods for promoting dendritic cell proliferation or differentiation |
11/07/2002 | US20020165137 Diagnosing, treating, preventing and/or prognosing disorders related to these polypeptides |
11/07/2002 | US20020165136 Induction of apoptosis of cancer cells using major histocompatibility complex class I peptides |
11/07/2002 | US20020165135 Compositions and methods related to canine IgG and canine IL-13 receptors |
11/07/2002 | US20020165134 Emulsion preconcentrates; triglyceride mixture |
11/07/2002 | US20020165133 Use of [gamma-hydroxy-N-methyl-leucine9] cyclosporin a for hair growth |
11/07/2002 | US20020165131 Histidine-rich glycoprotein |
11/07/2002 | US20020165129 Peptides and their use to ameliorate cell death |
11/07/2002 | US20020165128 Compositions and methods for proteolytically inactivating infectious agents using lactoferrin and related molecules |
11/07/2002 | US20020165127 Antidiabetic agents |
11/07/2002 | US20020165126 Method for inactivating gonadotrophs |
11/07/2002 | US20020165124 Dissolving amyloid plaque |
11/07/2002 | US20020165123 CXCR4 agonist treatment of hemapoietic cells |
11/07/2002 | US20020165122 Method and compositions for the treatment or amelioration of female sexual dysfunction |
11/07/2002 | US20020164962 Apparatuses, methods, and computer programs for displaying information on mobile units, with reporting by, and control of, such units |
11/07/2002 | US20020164799 Expression vector coding proteins for use in the treatment of cancer |
11/07/2002 | US20020164792 Identification of human cell lines for the production of human proteins by endogenous gene activation |
11/07/2002 | US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder |
11/07/2002 | US20020164788 Humanized antibodies to CD38 |
11/07/2002 | US20020164786 Novel telomerase |
11/07/2002 | US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors |
11/07/2002 | US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans |
11/07/2002 | US20020164768 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of thrombosis and vascular system disorders |
11/07/2002 | US20020164767 DNA encoding the human serine protease C-E |
11/07/2002 | US20020164761 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial propagation |
11/07/2002 | US20020164760 Catalytically active recombinant memapsin and methods of use thereof |
11/07/2002 | US20020164759 Dipeptidylpeptidase for use inthe treatment and prevention of periodonital disease |
11/07/2002 | US20020164758 Enzymatic polypeptide for use in the diagnosis and treatment of allergies, heart and respiratory disorders |
11/07/2002 | US20020164752 47508, a novel human histone deacetylase family member and uses thereof |
11/07/2002 | US20020164750 56634, a novel human phosphatidylinositol 4-phosphate 5-kinase family member and uses thereof |
11/07/2002 | US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders |
11/07/2002 | US20020164746 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of pain and nervous system disorders |
11/07/2002 | US20020164740 Polypeptide for use in diagnosis and treatment of brain and epileptic disorders |
11/07/2002 | US20020164738 Cell death inhibitory protein |
11/07/2002 | US20020164737 Novel human kinase and polynucleotides encoding the same |
11/07/2002 | US20020164735 Methods and compositions relating to a cardiac-specific nuclear regulatory factor |
11/07/2002 | US20020164734 Human pelota homolog |
11/07/2002 | US20020164725 Esterases |
11/07/2002 | US20020164722 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide |
11/07/2002 | US20020164719 Targeting pharmaceutical agents to injured tissues |
11/07/2002 | US20020164717 Suppression of endothelial cell proliferation; obtain cells, incubate with modulators, monitor adjustment in cell proliferation |
11/07/2002 | US20020164716 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
11/07/2002 | US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer |
11/07/2002 | US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
11/07/2002 | US20020164711 Megakaryocyte differentiation factor |
11/07/2002 | US20020164710 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
11/07/2002 | US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects |
11/07/2002 | US20020164704 Novel human monocyte chemotactic proprotein |
11/07/2002 | US20020164703 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
11/07/2002 | US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
11/07/2002 | US20020164699 Nucleotide sequences coding polypeptide for use the treatment of hypercholesterolaemia, diabetes, hypercholesterolaemia, hypoglycemia, graves disease, goiter, cushing's, addison, gastrointestinal and autoimmune diseases |
11/07/2002 | US20020164698 Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction |
11/07/2002 | US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease |
11/07/2002 | US20020164694 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infections |
11/07/2002 | US20020164693 TM4SF receptor polynucleotides, polypeptides, and antibodies |
11/07/2002 | US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies |
11/07/2002 | US20020164691 Human vomeronasal receptor-5 |
11/07/2002 | US20020164690 Receptor based antagonists and methods of making and using |
11/07/2002 | US20020164689 Nucleotide sequences codng polypeptide for use in the diagnosis and treatment of inflammation, autoimmune disease and sepsis |
11/07/2002 | US20020164687 Platelet-derived growth factor C, DNA coding therefor, and uses thereof |
11/07/2002 | US20020164686 Molecules designated B7L-1 |
11/07/2002 | US20020164684 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors, inflammation and shock |
11/07/2002 | US20020164682 Mammalian cerberus-like protein and compositions |
11/07/2002 | US20020164680 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
11/07/2002 | US20020164679 Polypeptides for use in the treatment of atherosclerosis and cardiovascular disorders |
11/07/2002 | US20020164669 Secreted protein HRGDF73 |
11/07/2002 | US20020164667 VEGFR-3 inhibitor materials and methods |
11/07/2002 | US20020164665 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof |
11/07/2002 | US20020164640 MyD88 adapter-like proteins |
11/07/2002 | US20020164625 Compositions isolated from bovine tissues and methods for their use |
11/07/2002 | US20020164624 VEGF-D expression in brain cancer |
11/07/2002 | US20020164620 Method for identifying compounds modulating sister chromatid separation |
11/07/2002 | US20020164615 Protein complex for use in the dianosis and treatment of nervous system disorders, alzheimer's and non-insulin dependent diabetes mellitus |
11/07/2002 | US20020164601 Enzymatic polypeptide for use in the treatment of infections |
11/07/2002 | US20020164582 Nucleotide sequences coding protein for use in the treatment of viral diseases |
11/07/2002 | US20020164576 Methods for diagnosis and treatment of diseases associated with altered expression of Nrf2 |
11/07/2002 | US20020164390 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use |
11/07/2002 | US20020164386 Topical applying glucosamine containing cream |
11/07/2002 | US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier |
11/07/2002 | US20020164372 Controlled release systems for polymers |